European Journal of Cancer
Volume 40, Issue 4 , Pages 521-528, March 2004

Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP)

  • C. Rodary

      Affiliations

    • Department of Public Health, Institut Gustave Roussy, 39 rue Camille Desmoulin, 94805 Villejuif, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-1-4211-4128; fax: +33-1-1211-5258
  • ,
  • V. Pezet-Langevin

      Affiliations

    • Department of Public Health, Institut Gustave Roussy, 39 rue Camille Desmoulin, 94805 Villejuif, France
  • ,
  • S. Garcia-Acosta

      Affiliations

    • Department of Public Health, Institut Gustave Roussy, 39 rue Camille Desmoulin, 94805 Villejuif, France
  • ,
  • T. Lesimple

      Affiliations

    • Centre Eugène Marquis, 35052 Rennes, France
  • ,
  • A. Lortholary

      Affiliations

    • Centre Paul-Papin, 49036 Angers, France
  • ,
  • M.C. Kaminsky

      Affiliations

    • Centre Alexis-Vautrin, 54511 Vandoeuvre-Les-Nancy, France
  • ,
  • J. Bennouna

      Affiliations

    • Centre René-Gauducheau, 44805 Saint-Herblain, France
  • ,
  • S. Culine

      Affiliations

    • Centre Val-d'Aurelle, 34094 Montpellier, France
  • ,
  • H. Bourgeois

      Affiliations

    • CHU La Milétrie, 86021 Poitiers, France
  • ,
  • Karim Fizazi

      Affiliations

    • Department of Medicine, Institut Gustave Roussy, 39 rue Camille Desmoulin 94805 Villejuif, France

Received 10 February 2003; received in revised form 18 September 2003; accepted 4 November 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(03)00960-2

doi:10.1016/j.ejca.2003.11.002

European Journal of Cancer
Volume 40, Issue 4 , Pages 521-528, March 2004